Section Review: Central & Peripheral Nervous Systems: Corticotropin releasing factor and Alzheimer's disease: recent developments with implications for more effective therapies

References

• TERRY RD, KATZMAN R: Senile dementia of the Alzhe- bner's type. Ann. Neurol. (1983) 14:497.
   PubMed Web of Science ®Google Scholar
• PRICE DL, WHITEHOUSE PJ, STRUBLE RG: Alzheimer's disease. Ann. Rev. Med. (1985) 36:349.
   PubMedGoogle Scholar
• COYLE yr, PRICE DL, DE LONG MR: Alzheimer's disease: a disorder of cortical cholinergic innervation. Science (1983) 219:1184–1190.
   PubMed Web of Science ®Google Scholar
• WHITEHOUSE PJ, VALE WW, ZWEIG EM et al.: ReductionIn corticotropin-releasing factor-like immunoreactivity In cerebral cortex in Alzheimer's disease, Parkinson's disease, and progressive supranuclear palsy. Neurology (1987) 37:905–909.
   PubMed Web of Science ®Google Scholar
• DE SOUZA EB, WHITEHOUSE PJ, KUHAR MJ, PRICE DL, VALE WW: Reciprocal changes in corticotropin-releas-ing factor (CRF)- like ittununoreactivity and CRF recep-tors in cerebral cortex of Alzheimer's disease. Nature (1986) 319:593-595. Key paper describing both deficits in CRF and upregulation of CRF receptors in Alzheimer's patients.
   Google Scholar
• VALE W, SPIESS J, RIVIER C, RIVIER J: Characterization of a 41-residue ovine hypothalamic peptide that stimu-lates secretion of corticotropin and I3-endorphin. Sci-ence (1981) 213:1394-1397. The first paper describing the characterisation of CRF.
   Google Scholar
• KOOB GF: Stress, corticotropin-releasing factor and behaviour. Perspect. Behaviour Med. (1985) 2:39-52.A comprehensive review of the behavioural effects of CRF.
   Google Scholar
• KOOB GF, BLOOM FE: Corticotropin-releasing factor and behaviour. Federation Proc. (1985)44:259–263.
   PubMedGoogle Scholar
• D1AMANT M, DE WED D: Structure-related effects of CRFand CRF-derived peptides: dissodation of behavioral, endocrine and autonomic activity. Neuroendocrinology (1993) 57:1071–1081.
   PubMed Web of Science ®Google Scholar
• RICHARD D: Involvement of corticotropin-releasing fac-tor in the control of food intake and energy expendi-ture. Ann. NY Acad. Sci. (1993) 697:155–172.
   PubMed Web of Science ®Google Scholar
• ROTH WELL NJ: Central effects of CRF on metabolism andenergy balance. Neurosci. Behav. Rev. (1990) 14:263–271.
   PubMed Web of Science ®Google Scholar
• FISHER LA, RIVIERJ, RIVER C et al.: Corticotropin-releas- ins factor (CRF) central effects on mean arterial pres-sure and heart rate in rats. Endocrinology (1982) 110:2222–2224.
   PubMed Web of Science ®Google Scholar
• LENZ HJ, FISHER LA, VALE WW, BROWN MR: Corticot-ropin-releasing factor, sauvagine and urotensin I: ef-fects on blood flow. Am. J. Physiot (1985) 249:R85–R90.
   Web of Science ®Google Scholar
• KIANG JG, WEI ET: Corticotropin-releasing factor inhib-its thermal injury. J. Pbarmacol. Exp. Then (1987) 243:517–520.
   PubMed Web of Science ®Google Scholar
• CROFFORD LJ, SANO H, KARALIS K et aL: Local secretion of corticotropin-releasing hormone in the joints of Lewis rats with inflammatory arthritis. J. Clin. Invest. (1992) 90:2555–2564.
   PubMed Web of Science ®Google Scholar
• CROFFORD LJ, SANO H, KARALIS K et al.: Corticotropin-releasing hormone in synovial fluids and tissues of patients with rheumatoid arthritis and osteoarthritis. J. Immunot (1993) 151:1587–1596.
   Google Scholar
• BISSE1 lh G, REYNOLDS GP, KILTS CD, WIDERLOV W, seNEMEROFF CB: Corticotropin-releasing factor-like itn-munoreactivity in senile dementia of the Alzheimer type. J. Am. Med. Assoc. (1985) 254:3067-3069. A paper describing the changes in CRF immunoreactivity in Alzhe-imer's disease.
   Google Scholar
• DE SOUZA EB, WHITEHOUSE PJ, PRICE DL, VALE WW: Abnormalities in corticotropin-releasing hormone (CRH) in Alzheimer's disease and other human disor-ders. Ann. IVY Acad. Sci. (1987) 512:237–247.
   PubMed Web of Science ®Google Scholar
• DE SOUZA EB: CRH defects in Alzheimer's and other neurologic diseases. Hospital Practice (1988) 23:59-71.Simplified overview of CAE defects in Alzheimer's and other neurologic diseases.
   Google Scholar
• GRIGORIADIS DE, S1RUBLE RG, PRICE DL, DE SOUZA EB: Normal pattern of labelling of cerebral cortical corticot-ropin-releasing factor (CRF) receptors in Alzheimer's discos evidence from chemical cross-linking studies. Neuropharmacology (1989) 28:761–764.
   PubMed Web of Science ®Google Scholar
• BISSE11E G, REYNOLDS GP, KILTS CD, WIDERLOV W, NEMEROFF CB: Corticotropin-releasing factor-like im-munoreactivity in senile dementia of the Alzheimer type. J. Am, Med. Assoc. (1985) 254:3067–3069.
   Web of Science ®Google Scholar
• MOURADIAN MM, FARAH JM, Jr., MOHR E et aL: Spinal fluid CRF reduction in Alzheimer's disease. Neuropep-tides (1986) 8:393–400.
   Google Scholar
• MAY C, RAPOPORT SI, TOMAI TP, CHROUSOS GP, GOLDPW: Cerebral spinal fluid concentrations of corticot-ropin-releasing hormone (CRH) and corticotropin (ACTH) are reduced in Alzheimer's disease. Neurology (1987) 37:535–538.
   PubMed Web of Science ®Google Scholar
• POMARA N, SINGH RR, DEPTULA D et al.: CSF cortico-tropin-releasing factor (CRF) in Alzheimer's disease: its relationship to severity of dementia and monoamine metabolites. Biological Psychiatry (1989) 26:500–504.
   PubMed Web of Science ®Google Scholar
• POWERS RE, WALKER LC, DE SOUZA EB et al.: Immuno-histochemical study of neurones containing corticot-ropin-releasing factor in Alzheimer's disease. Synapse (1987) 1:405–410.
   Google Scholar
• RA_ADSHEER FC, VAN HEERIKHUIZE JJ, LUCASSEN PJ et al.: Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am J. Psychiatry (1995) 152:1372–1376.
   Google Scholar
• RAADSHEER FC, TILDERS FJ, SWAAB DF: Similar age related increase of vasopressin colocalization in para-ventricular corticotropin-releasing hormone neurones In controls and Alzheimer's patients. J. Neuroendocrinol (1994) 6:131–133.
   PubMed Web of Science ®Google Scholar
• RAADSHER FC, OORSCHOT DE, VERWER RW, TILDERS FJ, SWAAB DF: Age-related increase lathe total number of corticotropin- releasing hormone neurones in the hu-man paraventricular nucleus in controls and Alzhe-hner's disease: comparison of the disector with an unfolding method. J. Comp. Neurot (1994) 339:447–457.
   PubMed Web of Science ®Google Scholar
• LESCH RE, IHL R, FROHLICH L et al.: Endocrine responses to growth hormone releasing hormone and corticot-ropin releasing hormone in early-onset Alzheimer's disease. Psychiatry Res. (1990) 33:107–112.
   PubMed Web of Science ®Google Scholar
• DODT C, DITTMANN J, HRUBY J et al.: Different regula-tion of adrenocorticotropin and cortisol secretion in young, mentally healthy elderly and patients with se-nile dementia of Alzheimer's type. J. Clin. Endocr. Metab. (1991) 72:272–276.
   PubMed Web of Science ®Google Scholar
• WHITEHOUSE, PJ, PRICE, DL, STRUBLE RG et al.: Alzhe-hner's disease and senile dementia: loss of neurones in the basal forebrain. Science (1982) 215:1237.
   PubMed Web of Science ®Google Scholar
• CRA`OVLEY JN, OLSCHOWKA JA, DIZ DI, JACOBOWITZ DM: Behavioral investigation of the co-existence of sub-stance P, corticotropin-releasing factor, and acetyl-cholinesterase in lateral dorsal tegmental neurones projecting to the medial frontal cortex of the rat. Peptides (1985) 6:891.
   PubMed Web of Science ®Google Scholar
• HILLHOUSE E, REICHLIN, S: Acetylcholine stimulates the secretion of corticotropin-releasing factor from pri-mary dissociated cell cultures of the rat telencephalon and dincephaion. Brain Res. (1990) 506:9–13.
   PubMed Web of Science ®Google Scholar
• DE SOUZA EB, BATTAGLIA G: Increased corticotropin-releasing factor receptors in rat cerebral cortex follow-ing chronic atrophic treatment. Brain Res. (1986) 397:401–404.
   PubMed Web of Science ®Google Scholar
• MILLARD WJ, ARENDASH GW, DUNN AJ, MEYER EM: Effects of nucleus basalts lesions on cerebral cortical concentrations of corticotropin-releasing hormone (CRH)-like immunoreactivity in the rat. Neurosci. Lett. (1990) 113:233–239.
   PubMed Web of Science ®Google Scholar
• CHEN R, LEWIS KA, PERRIN MU, VALE WW: Expression cloning of a human corticotropin-releasing-factor re-ceptor. Proc. Natl. Acad. Sci. USA (1993) 90:8967–8971.
   PubMed Web of Science ®Google Scholar
• CHANG CP, PEARSE RI, O'CONNELL S, ROSENFELD MG: Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. Neuron (1993) 11:1187–1195.
   PubMed Web of Science ®Google Scholar
• PERRIN MH, DONALDSON CJ, CHEN R, LEWIS KA, VALE WW: Cloning and functional expression of a rat brain corticotropin releasing factor (CliF) receptor. Endocri-nology (1993) 133:3058–3061.
   PubMed Web of Science ®Google Scholar
• VITA N, LAURENT P, LEFORT S et al.: Primary structure and functional expression of mouse pituitary and hu-man brain corticotrophin releasing factor receptors. FESS Lett. (1993) 335:1–5.
   PubMed Web of Science ®Google Scholar
• DE SOUZA EB: Corticotropin-releasing factor receptorsIn the rat central nervous system: characterization and regional distribution. J. Neuroscience (1987) 7:88–100.
   PubMed Web of Science ®Google Scholar
• DE SOUZA EB: In: Handbook of Chemical Neuroanatomy -Neuropeptide Receptors in the (NS, Part 111. Bjorklund A, 38. Hokfelt T, Kuhar MJ (Eds.), Elsevier, Amsterdam (1992):145–185.
   Google Scholar
• LOVENBERG TW, LIAW CW, GRIGORIADIS DE etal.: Clon-ing and characterization of a functionally distinct cor-ticotropin-releasing factor receptor subtype from rat brain. Proc. Natl. Acad. Sci. USA (1995) 92:836–840.
   Google Scholar
• KISHIMOTO T, PEARSE II RV, LIN CR, ROSENFELD MG: Asauvaghae/cortkotropin-releasing factor receptor ex-pressed in heart and skeletal muscle. Proc. Natl. Acad. Sci. USA (1995) 92:1108–1112.
   PubMed Web of Science ®Google Scholar
• PERRIN M, DONALDSON C, CHEN R etal.: Identificationof a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc. Natl. Acad. Sci. USA (1995) 92:2969–2973.
   Google Scholar
• LOVENBERG TW, CHALMERS DT, LIU C, DE SOUZA EB: CRF2. and CRF2A receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. Endocrinology (1995) 136:4139–4142.
   Google Scholar
• CHALMERS DT, LOVENBERG TW, DE SOUZA EB: Localis-ation of novel corticotropin-releasing factor receptor (01F2) naRNA to specific sub-cortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J. Neuroscience (1995) 15:6340–6350.
   PubMed Web of Science ®Google Scholar
• VAUGHAN, J, DONALDSON, C, B11 LENCOURT, J et al.:Urocortin, a mamtnallAn neuropeptide related to fish urotensin I and to corticotropin- releasing factor. Na-ture (1995) 378:287–291.
   Google Scholar
• BEHAN DP, LINTON EA, LOWRY PJ: Isolation of the human plasma corticotrophin-releasing factor-binding protein. J. Endocrinology (1989) 122:23–31.
   PubMed Web of Science ®Google Scholar
• LINTON EA, WOLFE CDA, BEHAN DP, LOWRY PJ: A spe-cific carrier substance for human corticotropin-releas-ing factor in late gestational maternal plasma which could mask the ACTH-releasing activity. Clin. Endocri-nology (1988) 28:315–324.
   PubMed Web of Science ®Google Scholar
• LINTON EA, BEHAN DP, SAPHIER PW, LOWRY PJ: Corti-cotropin-rekasing hormone binding protein: reduc-tion in the ACTH- releasing activity of placental but not hypothalamic CRH. J. Clin Endocr. Metab. (1989) 70:1574–1580.
   Web of Science ®Google Scholar
• SUDA, T, IWASHITA, M, TOZAWA etal.: Characterizationof CRII binding protein in human plasma by chemical cross-linking and its binding during pregnancy. J. Clin. Endocri. Metab. (1988) 67:1278–1283.
   Google Scholar
• ORTH ON, MOUNT CD: Specific high affinity binding protein for human corticotropin-releasing hormone in normal human plasma. Biocbem. Biophys. Res. Comm. (1987) 143:411-417. First paper describing the identification of CRF-BP in human plasma.
   Google Scholar
• ELLIS MJ, LIVESEY JH, DONALD RA: Circulating plasma corticotropin-releasing factor-like immunoreactivity. J. Neuroendocrinology (1988) 117:299–307.
   Google Scholar
• POTTER E, BEHAN DP, FISCHER WH et al.: Cloning and characterization of the cDNAs for human and rat corti-cotropin-releasing factor-binding proteins. Nature (1991) 349:423-426. First paper describing the cDNA sequence and biological activity of recombinant CRF-BP.
   Google Scholar
• POTTER E, BEHAN DP, LINTON EA et al.: The central distribution of a corticotropin-releasing factor (CRF)- binding protein predicts multiple sites and modes of Interaction with CRF. Proc. Natl. Acad. Sci. USA (1992) 89:4192-4196. First paper describing the brain distribution of CRF-BP in relation to CRF.
   Google Scholar
• POTTER E, SUTTON S, DONALDSON C etal.: The distribu- tion of CRF receptor mRNA expression in the rat brain and pituitary. Endocrine Soc. Abstracts (1994):217. First paper describing the regional brain distribution of CRFRa receptors in relation to CRF and CRF-BP.
   Google Scholar
• SUTTON SW, BEHAN DP, LAHRICHI SL et al.: Ligand requirements of the human corticotropin releasingfactor-binding protein. Endocrinology (1995) 136:1097-1102. This was the first paper describing the binding epitopes on CRF which are important for CRF-BP recognition.
   Google Scholar
• BEHAN DP, DE SOUZA EB, LOWRY PJ etal.: Corticotropin releasing factor (CRF) binding protein: a novel regula-tor of CRF and related peptides. Frontiers Neuroendocri-nology (1995) 16:362-382. A comprehensive review on CRF-BP.
   Google Scholar
• BEHAN, DP, CEPOI, D, FISHER WH etal.: Characterization of a sheep brain corticotropin releasing factor binding protein. Brain Res. (1995) 709:265-274. The first paper describing the biochemical characterization of CRF-BP in brain.
   Google Scholar
• BEHAN DP, P01 ITER E, SUTTON S etal.: Corticotropin-re-leasing factor-binding protein: a putative peripheral and central modulator of the CRF family of neuropep-tides. Ann. NY Acad. Sci. (1993) 697:1–8.
   Google Scholar
• HOFFMAN BJ, MEZEY E, BROWNSTEIN MJ: Cloning of aseretonin transporter affected by antidepressants. Sci-ence (1991) 254:579–580.
   PubMed Web of Science ®Google Scholar
• PACHOLOZYK T, BLAKELY RD, AMARA SG: Expression cloning of a cocaine-antidepressant sensitive human noradrenaline transporter. Nature (1991) 350:350–353.
   PubMed Web of Science ®Google Scholar
• GUASTELLA J, NELSON N, NELSON H eta!: Cloning and expression of a rat brain GABA transporter. Science (1990) 249:1303–1306.
   PubMed Web of Science ®Google Scholar
• BEHAN DP, HEINRICHS SC, TRONCOSO JC etal.: Displace-ment of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease. Nature (1995) 378:284-287. The first paper describing the utility of CRF-BP ligand inhibitors to elevate 'free' CRF levels and improve learning and memory in animals.
   Google Scholar
• MCGAUGH JL: Involvement of hormonal and neuro-modulatory systems in the regulation of memory stor-age. Ann. Rev. Neurosci. (1989) 12:255–287.
   PubMed Web of Science ®Google Scholar
• DACTLIR S, KADAR T, ROBINZON B, LEVY A: Cognitive deficits induced in young rats by long-term corticos-terone administration. Behavioral Neural Biol. (1993) 60:103–109.
   PubMedGoogle Scholar
• MARTINEZ JL: Memory drugs and hormones. Martinez JL, Kesner RP (Eds.), Academic Press, Orlando (1986).
   Google Scholar
• KOOB GF: Arousal, stress, and inverted U-shaped curves: implications for cognitive function. In: Cognitive Neuroscience. Weingartener H, Listner R (Eds.), Oxford Uni-versity Press (1991):300–313.
   Google Scholar
• FEKETE M, BALAZS M, TELEGDY G, SCHALLY AV: Effects of intracerebroventricular administration of ovine cor-ficotropin-releasing factor (CRF 1-41) on passive avoid-ance behaviour: lack of influence on monoamine 56. contents of limbic brain areas. Neuropeptides (1985) 6283–292.
   Google Scholar
• HONOUR LC, WHITE MIT: Pre- and postnatally adminis-tered ACTH, Organon 2766 and CRF facilitate or inhibit active avoidance task performance in young adult mice. Peptides (1988) 9:745–750.
   PubMed Web of Science ®Google Scholar
• DE FRANCE JF: The Septal Nuclei. Plenum, New York (1976).
   Google Scholar
• CHROUSOS GP, GOLD PW: The concepts of stress andstress system disorders. JAMA (1992) 267:1244–1252.
   PubMed Web of Science ®Google Scholar
• BEHAN DP, MACIEJEWSKI D, CHALMERS D, DE SOUZA EB: Corticotropin releasing factor binding protein (CRF-BP) is expressed in neuronal and astrocytic cells. Brain Res. (1995) 698:259–264.
   PubMed Web of Science ®Google Scholar
• MACIEJEWSK1 D, CROWE PD, DE SOUZA EB, BEHAN DP: Regulation of cortiootropin-releasing factor-binding protein expression in cultured rat astrocytes. JPET (1996) 278:455–461.
   PubMed Web of Science ®Google Scholar